RDY - CIK 0001135951
DR REDDYS LABORATORIES LTD trades as RDY and has a market capitalization of $11.10 B, making it the #885 largest US-listed company by market value. This page tracks DR REDDYS LABORATORIES LTD through 1,301 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-18 |
| 6-K | - | 2026-05-18 |
| 6-K | - | 2026-05-15 |
| 6-K | - | 2026-05-12 |
| 6-K | - | 2026-05-12 |
| 6-K | - | 2026-05-12 |
| 6-K | - | 2026-05-12 |
| 6-K | - | 2026-05-12 |
DR. REDDY'S LABORATORIES LTD. INVESTOR RELATIONS MEDIA RELATIONS
DR. REDDY'S LABORATORIES LTD. INVESTOR RELATIONS MEDIA RELATIONS
ACCELERATING INDIA’S DRUG DEVELOPMENT AND IMPROVING PATIENT
The largest companies sharing DR REDDYS LABORATORIES LTD's SEC industry classification (pharmaceutical preparations).
DR REDDYS LABORATORIES LTD (RDY) has a market capitalization of $11.10 B as of 2026-06-10, ranking #885 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.